More than half of patients can now survive a deadly skin cancer that was considered untreatable just a decade ago, say UK doctors. Ten years ago only one-in-20 patients would live for five years after being diagnosed with late-stage melanoma. Most would die in months. But drugs to harness the body's immune system mean 52% now live for at least five years, a clinical trial shows.

A space-age metal that formed part of the asteroid that destroyed the dinosaurs could provide a new method of treating cancer tumours selectively using light.

An "extraordinary transformation" is how doctors describe therapies for advanced melanoma.

The newest cancer sniffer might not be as cute as a sharp-nosed canine, but it could give doctors a new way to determine the best treatment for patients using just the melange of compounds in their breath. The eNose can detect with 85 percent accuracy if a person will respond to immunotherapy, say researchers in a paper published today in Annals of Oncology. That could make it an alternative to current methods of determining which cancer treatment is best suited to different patients.

Researchers didn’t know if it would work, but they had little to lose when they tried a new drug—a living cell reprogrammed to recognize and kill leukemia—on a dying 6-year-old.

Electromagnetic fields might help prevent some breast cancers from spreading to other parts of the body, new research has found. The study showed that low intensity electromagnetic fields hindered the mobility of specific breast cancer cells by preventing the formation of long, thin extensions at the edge of a migrating cancer cell. The research was done on cells in a lab, and the concept hasn’t yet been tested in animals or humans. The study was published today in the journal Communications Biology.

The story of CTVT—a contagious cancer that spreads from dog to dog—gets weirder all the time.

On a recent Saturday afternoon, in an estuary near Tampa Bay, Florida, I watched airboats move up and down the river banks, spraying massive plumes of weedkiller on to the vegetation. The state of Florida was trying to control and kill off scores of plant species. Nearby, children were lying out in the sun, though they knew better than to swim in the water, which has recently been blooming with toxic algae. Mists of weedkiller drifted downwind toward them.

A small team of Israeli scientists think they might have found the first complete cure for cancer. “We believe we will offer in a year’s time a complete cure for cancer,” said Dan Aridor, of a new treatment being developed by his company, Accelerated Evolution Biotechnologies Ltd. (AEBi), which was founded in 2000 in the ITEK incubator in the Weizmann Science Park. AEBi developed the SoAP platform, which provides functional leads to very difficult targets.

All cancers may be triggered by a rare rogue stem cell that has learned how to cheat death, according to new research. Scientists believe the discovery of the “cell of origin” could be a turning point in the battle against the disease. Lead researcher Professor Michael Lisanti, chair of translational medicine at University of Salford, said: “If, as we believe, we have found the beginning of the road, we may have to press the reset button on how we treat cancer with drugs.”

The plaintiff alleged that Johnson & Johnson's baby powder caused her mesothelioma, a form of cancer linked to asbestos exposure.

A form of cancer treatment Lauren Krelsham credits with giving her another chance to live will be made more widely available, with the Federal Government announcing $80 million towards a facility in Melbourne. The $105 million treatment centre will be housed at the Peter MacCallum Cancer Centre and will offer CAR T-cell therapy, Health Minister Greg Hunt said. The treatment involves removing some of a patient's immune system cells so they can be re-engineered in a lab, before they are reinserted to attack cancer cells.

But the Irish Society of Medical Oncologists (ISMO) said there was no “magic diet” to help patients beat cancer – and this meant following their doctor’s advice and following a high protein, high calorie diet.

Positive early results from the first phase of human testing for a unique colorectal cancer vaccine are proving promising. A newly published study outlining the Phase I trial results suggests the vaccine is safe, and stimulates immune activation, paving the way for larger human trials.

Stanford researchers have developed synthetic proteins that can rewire cancer cells in a lab dish by co-opting critical disease-associated pathways.

Researchers at the University of Virginia School of Medicine have shed light on how cancers hijack the body’s natural wound-healing response to grow and spread. The researchers have identified specific processes within endothelial cells – the cells that line blood vessels – that tumors use to build out their own blood supply. These processes are normally used by the body to repair tissue, heal injuries and grow new blood vessels, but tumors co-opt them to create blood vessels that will nourish them and feed their growth.

A new type of drug that targets a genetic weakness in an untreatable childhood brain cancer could become the first ever treatment designed to target the disease. The prototype treatment could also offer hope for patients with the rare and devastating ‘stone man syndrome’ – in which muscles and ligaments turn to bone.

Scientists want to ‘take away the fear’ by halting mutation of cells, even in advanced cases

GMO Impossible Burger has tested positive for glyphosate. Glyphosate is known to the State of California to cause cancer.

NHS patients with lymphoma have for the first time been given a pioneering treatment that genetically reprogrammes their immune system to fight cancer. Mike Simpson, 62, from Durham, says his cancer is now "on the run". The therapy, called CAR-T, is a "living drug" that is tailor-made for each patient using their body's own cells